Cancer Translational Research Horizons (CTR Horizons) 2026
In its fourth consecutive year, Cancer Translational Research Horizons 2026 (CTR Horizons) continues to bring together innovators, investigators, clinicians, trainees, and industry professionals working at the forefront of cancer translational research.
The two-day symposium is scheduled for November 25–26, 2026, at the Holiday Inn & Suites Montreal Centre-ville Ouest.
As in previous years, CTR Horizons is designed to promote the exchange of ideas across sectors, strengthen collaborations, and accelerate the translation of scientific discoveries into clinical applications that improve patient outcomes. It also aims to support and inspire participants in their journey to translate laboratory discoveries into novel clinical applications.
Registration and abstract submissions are now open. You can share your latest research by submitting an abstract during registration for the opportunity to present your work as an oral or poster presentation.
For any additional information, do not hesitate to contact the organizers at MCTRC [at] ladydavis.ca
Ìý
